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Appropriateness of prescribing has gained much atten-tion in studies about the quality of health care.1-5 This
is particularly true for elderly and nursing home patients.
In view of the high rate of drug use, age-related pharma-
cokinetic and pharmacodynamic changes, and multiple co-
morbidities, elderly patients are at a higher risk of adverse
drug effects (ADEs).1,2,6,7 Schmader et al.2 defined appro-
priate prescribing as the selection of a medication and in-
structions for its use that agree with accepted medical stan-
dards. These standards are based on efficacy, ADEs, and
cost-effectiveness, and are derived from national and inter-
national guidelines, clinical trials, and expert opinion. To-
day, the concept of evidence-based medicine is included in
daily medical practice. Evidence-based medicine is not
only based on external clinical evidence, but also on indi-
vidual clinical expertise.8 To assess medication appropri-
ateness, indicators that reflect deviations from national
pharmacotherapy guidelines and drug formularies should
be used.9 The development of pharmacotherapy guidelines
specifically for the elderly is generally limited. In the
Netherlands, initiatives for Dutch nursing home patients
are currently being developed.10
Several tools have been developed to assess the appro-
priateness of prescribing in the elderly.1,5 Many of these
were designed for assessing medication appropriateness in
elderly outpatients rather than nursing home residents. In-
ternationally, several studies have been published on pre-
scribing indicators for elderly outpatients and nursing home
residents.11-15 In the Netherlands, however, studies on pre-
scribing indicators are currently lacking. Prescribing indi-
cators used in one healthcare system are not automatically
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applicable to other healthcare systems due to differences in
national pharmacotherapy guidelines and drug formula-
ries. Furthermore, for many prescribing indicators, infor-
mation on clinical status, such as laboratory results or diag-
noses, is necessary. This hampers a quick and effective use
of these indicators because in most countries, such as the
Netherlands, clinical information is not readily available in
pharmacies. Therefore, we wanted to evaluate prescribing
in nursing homes with indicators that could be used with
pharmacy data only. 
Appropriateness criteria for medication use in nursing
homes developed by Beers et al.11 were based on expert
consensus. They consisted of a list of 23 medications that
should be avoided and 13 medication doses, frequencies, or
prescription durations that generally should not be exceed-
ed. An update, including clinical information such as the
prescribing indication and potassium level monitoring, was
published in 1997.12 As Beers’ criteria list several medica-
tions that are not available in the Netherlands or are not in
accordance with Dutch pharmacotherapy standards, some
of these criteria cannot be applied to Dutch nursing homes. 
In 1997, Lunn et al.7 developed a set of 18 explicit crite-
ria, based on expert opinion, to identify inappropriate pre-
scribing in 101 nursing home residents in the UK. For 7 of
the 18 criteria, information on clinical status or diagnoses
of the residents was necessary, again making them unsuit-
able for use with pharmacy prescription data only, al-
though some of them could be incorporated. Two Swedish
studies assessing medication appropriateness used criteria
that were based on Swedish guidelines for measuring inap-
propriate use of psychotropic drugs in the elderly.13,14 In 1
study, the availability of clinical information for 4 of 13
criteria was required13; in the other study, this was the case
for 1 out of 10.14
The Medication Appropriateness Index (MAI), devel-
oped by Hanlon et al. in 1992,15 was found to be the most
reliable and valid instrument for assessing medication ap-
propriateness in elderly outpatients.1 To our knowledge,
the MAI has not been used to assess medication appropri-
ateness in nursing homes. In view of the differences in
drug use and living circumstances between elderly outpa-
tients and nursing home residents, criteria for medication
appropriateness are not necessarily the same for both pop-
ulations. The MAI consists of 10 questions assessing the
appropriateness of a prescribed medication. For 4 ques-
tions, information on diagnoses is necessary. The other 6
questions might be suitable for use with pharmacy pre-
scription data only, such as, “Are there clinically signifi-
cant drug– drug interactions?” and “Is there unnecessary
duplication with other drug(s)?” However, we considered
aspects concerning directions of use, such as patient
leaflets, not to be as relevant to the appropriateness of
nursing home prescribing as nurses ensure adequate ad-
ministration of the drugs. 
Recently, a list of 12 quality indicators based on litera-
ture review and expert panel consideration was published.5
For 5 quality indicators, clinical information such as drug
indication, response to therapy, or renal function was need-
ed. One indicator concerned a drug not available on the
Dutch market. Another indicator concerned patient educa-
tion, an item that could be relevant in view of monitoring
ADEs by caregivers. The quality indicators that could be
used with pharmacy prescription data only included the
availability of a medication list, periodic drug regimen re-
view, avoidance of drugs with strong anticholinergic prop-
erties, and avoidance of barbiturates, although we consider
the latter a less clinically relevant problem in view of the
limited use of barbiturates in the Netherlands.
We found the indicators described above not suitable for
our evaluation of drug use with only pharmacy prescrip-
tion data as the information source. Therefore, we decided
to develop prescribing indicators based solely on prescrip-
tion data obtained from hospital pharmacies to evaluate
drug use in 2 Dutch nursing homes. In an earlier study among
nursing home patients, we found that use of benzodiazepines,
loop diuretics, ulcer-healing drugs, and nonsteroidal antiin-
flammatory drugs (NSAIDs) was relatively high and the du-
ration of drug use was relatively long.16 We expected that
prescribing of these drugs could potentially be improved.
Therefore, we focused on these 4 drug groups. 
Methods
SETTING
The study was carried out in 2 nursing homes: 1 for somatic care
(home A; 134 residents) and 1 for psychogeriatric care (home B; 120
residents). Both institutions were comparable with regard to the medical,
pharmaceutical, and nursing care provided. Five nursing home physi-
cians (3 in home A, 2 in home B) provided medical care on a daily basis.
Each ward was visited twice a week, and a nursing home physician was
on call 24 hours a day. Both facilities were served by the same hospital
pharmacy. All drugs dispensed to the residents were registered in the
hospital pharmacy computer system. Any changes in medication were
updated on a daily basis in the hospital pharmacy computer system and a
complete medication history was kept for each resident. Medication was
administered to nursing home residents based on information recorded in
the computer system, such as drug, dosage, and route and time of admin-
istration. Hospital pharmacists carried out medication surveillance. At
the time of the study, no computerized medication surveillance was
available. Clinical information on patients is not readily available to hos-
pital pharmacists in the Netherlands, and hospital pharmacists do not vis-
it wards regularly. If prescriptions lead the pharmacist to query for inap-
propriateness and clinical information is needed, then the prescribing
physician is contacted by telephone.
DEVELOPMENT OF PRESCRIBING INDICATORS
We sought to evaluate prescribing practices with regard to NSAIDs,
benzodiazepines, diuretics, and ulcer-healing drugs by use of pharmacy
prescription data only. The prescribing indicators we developed fell into 2
groups (Table 1).17,18 Indicators in group (a) were descriptive in nature and,
consequently, no optimal value was defined. We calculated the proportion
of patients in each nursing home who were prescribed benzodiazepines,
NSAIDs, diuretics, and/or ulcer-healing drugs. Group (b) indicators re-
flected potentially suboptimal prescribing. Examples of these indicators
that were applied to all 4 drug groups were number of patients who used
drugs outside the regional drug formulary and number of patients who
used >1 drug from the same therapeutic drug class (e.g., 2 benzodi-
azepines, 2 ulcer-healing drugs, or 2 NSAIDs). Both indicators could
identify potentially suboptimal prescribing. The latter indicator was not
applied to the group of diuretics, as the combination of a loop diuretic
and a thiazide diuretic may sometimes be useful in heart failure and hy-
pertension.
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The appropriateness of drug dosage was assessed by comparing the
actual prescribed daily dose (PDD)19 with the recommended dose for the
elderly, expressed as the defined daily dose (DDD).20 For benzodiazepines,
the recommended dosage for elderly people is 0.5 DDD.17 For the other
drug groups, the recommended dosage was set on 1 DDD, as no specific
recommendation for elderly patients exists.18
Furthermore, 2 drug combinations were studied, both concerning
NSAIDs. First, coprescribing of NSAIDs and loop diuretics was evaluat-
ed because NSAIDs may decrease the efficacy of diuretics and induce
congestive heart failure.18,21 Second, the concomitant use of gastroprotec-
tive drugs (proton-pump inhibitors [PPIs]) during NSAID therapy was
studied. In view of the risks of NSAID therapy in the elderly,22 not to pre-
scribe a gastroprotective drug concomitantly could be regarded as subop-
timal prescribing. 
EVALUATION OF DRUG PRESCRIBING BY PRESCRIBING
INDICATORS
We evaluated the prescribing of benzodiazepines, NSAIDs, diuretics,
and ulcer-healing drugs retrospectively by using the prescribing indica-
tors described above. Pharmacy prescription data were collected for 1
day (point-prevalence). For 1 of the indicators (drug choice outside the
regional drug formulary), we evaluated drug use against the regional
drug formulary,23 which was based upon national evidence-based pre-
scribing guidelines.18,24 Table 2 presents the drugs listed in the regional
drug formulary.23
VERIFICATION OF PRESCRIBING INDICATORS
To assess the usefulness of the indicators, we verified the cases of po-
tentially suboptimal prescribing by means of an interview with one of
the prescribers. In a sample of patients (n = 25) reflecting the range of
patients in whom the indicators suggested potentially suboptimal pre-
scribing, the medical charts were reviewed together with information
from one of the prescribers to ascertain whether prescribing for these pa-
tients was indeed suboptimal. For 1 indicator (i.e., coprescribing of
NSAIDs with gastroprotective drugs), patients given both drugs — sug-
gesting optimal prescribing — were reviewed. The information was col-
lected during a 3-hour interview.
Results
EVALUATION OF DRUG PRESCRIBING BY PRESCRIBING
INDICATORS
The results are summarized in Table 1. The results with re-
gard to the indicators assessing potential suboptimal prescrib-
ing (group [b] indicators) are also briefly described below. 
Benzodiazepines were prescribed at daily dosages >0.5
DDD in 11 of 41 patients in home A and 8 of 33 patients
in home B. Three patients were prescribed a nonformulary
benzodiazepine. Six of 41 and 1 of 33 patients received >1
benzodiazepine at the same time. NSAIDs were prescribed
at dosages >1 PDD in 7 of 14 and 1 of 6 patients, respec-
tively. All NSAIDs prescribed were formulary drugs. No
patients received >1 NSAID. Three of 14 and 1 of 6 patients
were prescribed a loop diuretic simultaneously. Eleven of 14
and 6 of 6 NSAID users, respectively, were not prescribed
a gastroprotective drug concomitantly. Diuretics were pre-
scribed at dosages >1 PDD in 7 of 41 and 3 of 16 patients,
respectively. All diuretics prescribed were formulary
drugs. Ulcer-healing drugs were prescribed at dosages >1
PDD in 8 of 34 and 4 of 16 patients, respectively. All ul-
cer-healing drugs prescribed were formulary drugs. There
were no patients that were prescribed >1 ulcer-healing
drug at the same time.
VERIFICATION OF PRESCRIBING INDICATORS
The medication of 25 patients (all from home A) with
potentially suboptimal prescribing was reviewed using the
medical charts and subsequently discussed with one of the
prescribing nursing home physicians. We selected 8 pa-
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Table 1. Evaluation of Drug Use in 2 Dutch Nursing Homesa
Benzodiazepines NSAIDs Diuretics Ulcer-Healing Drugs 
Indicator Home A Home B Home A Home B Home A Home B Home A Home B 
a. Descriptive prescribing indicators 
Users, n (%) 41 (30.6) 33 (27.5) 14 (10.4) 6 (5.0) 41 (30.6) 16 (13.3) 34 (25.3) 16 (13.3)
hypnotics 37 (27.6) 19 (15.8)
anxiolytics 7 (5.2) 15 (12.5)
b. Indicators of potential suboptimal prescribing (n)
PDD >0.517 11 8
PDD >1 7 (7)b 1 7 (5)b 3 8 (5)b 4
Use of drugs outside 1 2 0 0 0 0 0 0
formulary
>1 drug from same 6 1 0 0 0 0
drug class
Combination with loop  3 1
diuretic18
No combination with 11 (8)b,c 6
gastroprotective drug18
DDD = defined daily dose; NSAID = nonsteroidal antiinflammatory drug; PPD = prescribed daily dose; i.e., the daily dose (in mg) divided by the DDD
(in mg).
aNursing home A provides mainly somatic care (n = 134). Nursing home B provides mainly psychogeriatric care (n = 120).
bNumber of patients included in the review for verifying prescribing indicators.
cOnly NSAID users who were coprescribed a proton-pump inhibitor were included.
tients who received an NSAID and a PPI concomitantly.
We inquired whether the PPI was prescribed to counteract
the gastrotoxicity of the NSAID, thus suggesting optimal
prescribing. Indeed, in 2 patients the PPI was prescribed to
treat gastrointestinal ADEs of the NSAID. For the remain-
ing 6 patients, other reasons for prescribing a PPI existed.
Two patients had a diaphragmatic hernia and were pre-
scribed a PPI to prevent erosive damage due to reflux
esophagitis, and 1 was diagnosed with a duodenal ulcer.
One patient was diagnosed with reflux esophagitis, and
therapy with a histamine (H2)-antagonist was not effective.
One patient experienced nausea and vomiting as a result of
antiparkinsonian drug therapy (levodopa/carbidopa) and
was subsequently prescribed a PPI. One patient was bedrid-
den due to spinal cord injury and was prescribed the PPI to
prevent erosive damage due to reflux esophagitis.
Five patients received an ulcer-healing drug (PPI) in
dosages >1 PDD (equivalent to omeprazole 40 mg). Ac-
cording to the nursing home physician, this might have
been due to the fact that some prescribers tend to start with
a high dosage to effectively heal the symptoms and taper
the dosage when acute symptoms have diminished. Three
patients were diagnosed with ulcus ventriculi or ulcus duo-
deni and were, therefore, given ulcer-healing drugs in these
dosages. One of these patients was first prescribed an H2-
receptor antagonist, but experienced central adverse ef-
fects. Of the other 2 patients, 1 patient was diagnosed with
reflux esophagitis and hiatus hernia and was prescribed a
PPI in high dosage by a medical specialist. This therapy
was subsequently continued. The other patient was given
methotrexate and experienced nausea that responded well
to PPI therapy. According to the physician, ADEs were not
seen with these high dosages of PPIs. 
Seven patients were prescribed NSAIDs above the rec-
ommended dosage. According to the nursing home physi-
cian, this was the result of careful dose adjustments that ul-
timately led to these relatively high dosages. Three of these
patients were prescribed acetaminophen 2– 4 g/d before
the NSAID was started. Severe rheumatoid arthritis and
severe pain were reasons for prescribing NSAIDs in such
high dosages. The necessity for these high dosages was
reevaluated periodically, as well as the occurrence of po-
tential gastrointestinal and renal adverse effects.
Five patients received loop diuretics at a dosage higher
than recommended. All of these patients had a diagnosis of
heart failure. Careful dose adjustments in these patients
had ultimately led to these relatively high dosages. Metabol-
ic disorders such as hypokalemia were frequently moni-
tored by measuring plasma potassium levels. 
Discussion
In our study, prescribing practices in 2 Dutch nursing
homes were generally in agreement with regional and na-
tional guidelines. 
DRUG USE BASED ON PRESCRIBING INDICATORS
Number and Percentage of Users of Drug Groups
In the nursing home for somatic care (home A), approx-
imately twice as many hypnotics, NSAIDs, ulcer-healing
drugs, and diuretics were prescribed compared with the
nursing home for psychogeriatric care (home B). This may
reflect the somatic disorders that these residents experi-
ence. This descriptive indicator reflects overall prescribing
practice and can be used to monitor changes in prescribing
in-house over time. Comparison of prescribing practices
between these homes is difficult in view of the differences
in comorbidity.
Dosage of Drug Groups
The percentage of the residents receiving dosages high-
er than recommended varied among the nursing homes,
with a minimum of 1 of 6 patients and a maximum of 7 of
14 patients affected. From the interview data, it was found
that often the high dosages were the result of titration of
the dosage based on the clinical effect. This was the case in
particular for NSAIDs, diuretics, and ulcer-healing drugs.
This indicator does not necessarily reflect suboptimal pre-
scribing regarding these drug groups. Insight into the indi-
cation for which the drug is prescribed is needed to evalu-
ate whether a dosage is too high. 
Use of Nonformulary Drugs
Overall, 3 patients were prescribed nonformulary drugs
for the drug groups studied.  These patients received non-
formulary benzodiazepines (flurazepam, midazolam). For
these drugs, alternative formulary drugs were available and
recommendations with regard to substitution could be made.
Duplication of Drugs
More than 1 drug from the same drug class was prescribed
to 7 patients, and it concerned only benzodiazepine users. It
may be worthwhile to limit prescribing to 1 benzodiazepine. 
Combination of Drugs
Two indicators assessed the combination of drugs. One
indicator identified prescribing of an NSAID and a loop
diuretic, which was the case in 3 of 14 and 1 of 6 NSAID
International Reports
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NSAIDs = nonsteroidal antiinflammatory drugs.
users, respectively. Prescribing practices may be improved
on this point in view of the increased risk of congestive
heart failure due to potential drug interactions, although in-
dividual risk factors such as prevalent heart failure are to
be taken into account. The other indicator assessed poten-
tial suboptimal prescribing when no gastroprotective drug
was prescribed with an NSAID. A relatively high number
of NSAID users did not receive a gastroprotective drug
concomitantly. These results indicate that prescribing prac-
tices can be improved. The results are in line with a recent-
ly published study on elderly NSAID users.25
VERIFICATION OF PRESCRIBING INDICATORS
From the interview and chart review data, we concluded
that the prescribing indicators we investigated did not al-
ways identify suboptimal prescribing, as other reports have
also found.26,27 An indicator that performed well was the
combination of gastroprotective drugs and NSAIDs. This
indicator reflects suboptimal prescribing in view of the
risks of gastrotoxicity of NSAIDs in the elderly.22 In the in-
terview, the physician stated that NSAID -related gastroin-
testinal toxicity does not present often in clinical practice,
and this led nursing home physicians to question the clini-
cal relevance of preventive gastroprotective measures. Re-
cently, the nursing homes under study have changed their
prescribing policies on this point. Currently, guidelines rec-
ommend prescribing gastroprotective medication to all el-
derly people who chronically use NSAIDs. 
Indicators that assessed drug dosages above recommend-
ed values for NSAIDs, ulcer-healing drugs, and diuretics did
not perform well. Often, good reasons for prescribing these
high dosages existed, with the main reason being that lower
dosages were not effective. Potential adverse effects were
known to the prescribers and monitored periodically. Fur-
thermore, drug doses are often dependent on the indication,
and several “ideal” dosages per drug may exist depending
on the indication. DDD values have been developed for pur-
poses other than monitoring prescription appropriateness
and, therefore, are unsuitable to assess appropriateness of
drug dosages of these drug groups. 
Indicators that are to reflect suboptimal prescribing
should be sensitive and specific. It is often difficult to de-
rive prescribing indicators solely from guidelines and for-
mularies. This is particularly true for elderly patients, in
view of the complex comorbidity and often individualized
pharmacotherapy on the basis of clinical parameters. Ef-
forts should, therefore, be directed toward development of
indicators that take these issues into account. In the near
future, when both clinical data, such as laboratory values,
and pharmacy prescription data can be linked in automated
databases, incorporation of certain clinical data in prescrib-
ing indicators may be feasible.
LIMITATIONS
We interviewed only 1 nursing home physician. There-
fore, it was not always possible to determine the exact rea-
sons for prescribing by colleague physicians in the nursing
home. However, because we also reviewed medical charts,
most information on prescribing and medical diagnoses
could be traced. Another limitation of our study was that
we did not verify all prescribing indicators used in the drug
evaluation, such as whether use of >1 drug from the same
class was justified. Another issue is that we evaluated only
a limited number of patients from home A for verification
of the prescribing indicators. Although the indicators main-
ly dealt with medication for somatic conditions, it would be
interesting to review patients from the psychogeriatric nurs-
ing home as well. Furthermore, this article presents results
from a small pilot study, and findings on the appropriate-
ness of prescribing cannot be generalized. However, the
prescribing indicators developed could provide a useful
tool to evaluate prescribing appropriateness.
Summary
This pilot study demonstrated that prescribing indicators
based solely on pharmacy prescription data are a useful
tool to evaluate drug prescribing. With some of these indi-
cators, such as the lack of concomitant gastroprotective
therapy in NSAID users or duplicate benzodiazepine thera-
py, we were able to identify cases of potentially suboptimal
therapy. However, other indicators, such as those based on
drug dosages or that addressed the combination of certain
drugs, were not suitable for identification of suboptimal
prescribing. Clinical information from the physician was
necessary to obtain further insight into the appropriateness
of prescribing. 
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EXTRACTO
OBJETIVO: Evaluar el uso de medicamentos en 2 domicilios para el
cuidado de enfermos (254 residentes) en Holanda mediante el desarrollo
y la evaluación de indicadores de prescripción basados en datos de
prescripción registrados en el sistema de computadora de la farmacia.
MÉTODOS: Se evaluó la prescripción de benzodiazepinas, antiinflamatorios
noesteroidales, medicamentos para el tratamiento de úlceras, y diuréticos.
Se utilizaron indicadores de prescripción para identificar la prescripción
que potencialmente no estaba de acuerdo con las guías de prescripción
nacional y regional. Se utilizaron indicadores descriptivos tales como el
número y porcentaje de usuarios. También se utilizaron indicadores que
reflejan una prescripción potencialmente subóptima tales como el uso de
medicamentos que no están en el formulario de medicamentos regional, el
uso de más de 1 medicamento de la misma categoría, y la prescripción de
dosis de medicamentos sobre la recomendada. Cuando se encontró que la
prescripción era potencialmente subóptima, se verificó los hallazgos
mediante entrevista con 1 de los médicos.
RESULTADOS: Los indicadores de prescripción evaluados generalmente
estuvieron en armonía con las guías nacional y regional. Sin embargo, se
encontró que, en un número relativamente alto de pacientes, se
prescribieron agentes antiinflamatorios noesteroidales sin prescribir
concomitantemente agentes gastroprotectores. Luego de entrevistar al
médico y revisar el expediente clínico del paciente, se encontró que
algunos indicadores de prescripción, como dosis mayor a la recomendada,
no representaban necesariamente una prescripción subóptima. 
CONCLUSIONES: Este estudio piloto demostró que indicadores de
prescripción basados únicamente en datos de prescripción obtenidos de
la farmacia pueden ser una herramienta útil para evaluar los patrones de
prescripción de medicamentos. Con algunos de los indicadores de
prescripción se identificaron casos de prescripción potencialmente
subóptima, y se necesitó obtener información clínica del médico para
ayudar en el discernimiento de la adecuacidad de la prescripción.
Luz M Gutiérrez 
RÉSUMÉ
OBJECTIF: Le but de cette étude était d’évaluer l’utilisation des
médicaments dans 2 centres d’hébergement pour personnes âgées (254
personnes) de Hollande. Pour ce faire, des indicateurs ont été développés
et appliqués à la base de données des ordonnances pharmaceutiques.
MÉTHODES: Les auteurs ont évalué la prescription des benzodiazépines,
des anti-inflammatoires non-stéroidiens (AINS), des médicaments anti-
ulcéreux, et des diurétiques. Les indicateurs ont servi à identifier les
ordonnances qui ne correspondaient pas aux normes nationales et
régionales de prescription. Des indicateurs descriptifs, tels le nombre et
le pourcentage d’utilisateurs ont été utilisés. D’autres indicateurs visaient
à identifier l’utilisation potentiellement sous-optimale telle que
l’utilisation de médicaments hors formulaire, l’utilisation de plus d’un
principe actif au sein de la même classe pharmacologique et finalement
les doses de médicaments qui dépassaient les doses recommandées.
Lorsqu'une utilisation potentiellement non appropriée était identifiée, les
prescripteurs étaient rencontrés.
RÉSULTATS: Les indicateurs de prescription ont démontré un bon accord
avec les normes nationales et régionales. Cependant, la prescription
d’AINS sans cytoprotection a été fréquemment rencontrée. La rencontre
avec les prescripteurs et la révision des dossiers a démontré que certains
indicateurs, notamment ceux visant les doses élevées, n’indiquaient pas
nécessairement une utilisation sous-optimale.
CONCLUSIONS: Ce projet pilote a démontré que des indicateurs de
prescription basés uniquement sur les bases de données d’ordonnances
peuvent être utiles pour évaluer la prescription de médicaments. Ces
indicateurs ont permis d’identifier des cas de prescription sous-optimale.
Cependant, d’autres indicateurs, dont ceux portant sur les doses trop
élevées, n’ont pas permis d’identifier de façon fiable l’utilisation non
appropriée et l’information obtenue des prescripteurs était nécessaire
pour évaluer la justesse de l’utilisation clinique des médicaments.
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